Hyphens Pharma inks MoU with A*STAR for Derma research
Singapore, March 22 -- Hyphens is currently licensing sugar-based surfactant micro-emulsions technology from A*STAR's Institute of Chemical and Engineering Sciences (ICES).
By leveraging A*STAR's research and development capabilities, it is envisioned that this MoU will enable Hyphens to develop innovative and differentiated dermatological products to address unmet market needs.
Hyphens is a Singapore-headquartered ASEAN specialty pharma company. Operating in six countries across the region, Hyphens has a strong medical, regulatory and commercial capability. Dermatology is a key therapeutic focus field where Hyphens markets products under the brands "Ceradan" and "TDF".
Published by HT Digital Content Services with permission from BioS...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.